Early Rivaroxaban for Acute Ischemic Stroke or TIA Patients With Atrial Fibrillation: a Prospective, Multicenter, Cohort Study
Latest Information Update: 01 Oct 2024
At a glance
- Drugs Rivaroxaban (Primary)
- Indications Stroke
- Focus Adverse reactions
- Acronyms ERSAF
Most Recent Events
- 25 Sep 2024 Planned End Date changed from 30 Jun 2024 to 30 Nov 2024.
- 25 Sep 2024 Planned primary completion date changed from 30 Jun 2024 to 30 Nov 2024.
- 30 Dec 2023 Planned End Date changed from 30 Sep 2023 to 30 Jun 2024.